Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Edesa Biotech Inc (EDSA)

Edesa Biotech Inc (EDSA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 108,036
  • Shares Outstanding, K 13,256
  • Annual Sales, $ 330 K
  • Annual Income, $ -6,360 K
  • 60-Month Beta 0.71
  • Price/Sales 348.12
  • Price/Cash Flow N/A
  • Price/Book 4.86
Trade EDSA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.34
  • Number of Estimates 2
  • High Estimate -0.27
  • Low Estimate -0.42
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -54.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.43 +83.97%
on 08/25/21
12.00 -32.08%
on 09/20/21
+3.69 (+82.74%)
since 08/24/21
3-Month
4.15 +96.39%
on 08/19/21
12.00 -32.08%
on 09/20/21
+2.66 (+48.45%)
since 06/24/21
52-Week
4.05 +101.00%
on 01/04/21
12.00 -32.08%
on 09/20/21
+0.70 (+9.40%)
since 09/24/20

Most Recent Stories

More News
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients

Study unblinded due to strong efficacy signal for 28-day mortality endpointCritically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over Standard of CareData monitoring...

EDSA : 8.15 (-5.67%)
Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference

TORONTO, ON / ACCESSWIRE / September 9, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Dr....

EDSA : 8.15 (-5.67%)
Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule

Delta variant contributes to rapid enrollment amid growing scientific rationale for targeting Toll-like Receptor 4 (TLR4)Blinded interim analysis from Phase 2/3 study expected in current quarter

EDSA : 8.15 (-5.67%)
Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial results for the three and nine months ended June...

EDSA : 8.15 (-5.67%)
Edesa Biotech Extends Dermatitis Study to Canada

TORONTO, ON / ACCESSWIRE / July 13, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that the company...

EDSA : 8.15 (-5.67%)
This Could Massively Disrupt the $24.35 Billion NSAID Market

As the standard first-line treatment for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, ...

TRIL : 17.53 (+0.46%)
EDSA : 8.15 (-5.67%)
ACRS : 18.07 (+0.33%)
BMY : 60.23 (-0.66%)
ATBPF : 0.9756 (-0.45%)
TRIL.TO : 22.17 (+0.45%)
ATE.TO : 1.22 (unch)
Edesa Biotech Team Expands Leadership Team with Key Manufacturing Appointment

TORONTO, ON / ACCESSWIRE / June 23, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced the appointment...

EDSA : 8.15 (-5.67%)
Thinking about buying stock in Wells Fargo, ContextLogic, Novan, Intel Corp, or Edesa Biotech?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WFC, WISH, NOVN, INTC, and EDSA.

EDSA : 8.15 (-5.67%)
INTC : 54.22 (+0.35%)
NOVN : 8.14 (-3.78%)
WISH : 6.02 (-1.87%)
WFC : 47.92 (+0.25%)
Edesa Biotech Reports Favorable Review of COVID-19 Study

TORONTO, ON / ACCESSWIRE / June 18, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported that an independent...

EDSA : 8.15 (-5.67%)
Edesa Biotech to Attend BIO Digital 2021

TORONTO, ON / ACCESSWIRE / June 8, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that the company's...

EDSA : 8.15 (-5.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 9.04
2nd Resistance Point 8.83
1st Resistance Point 8.49
Last Price 8.15
1st Support Level 7.94
2nd Support Level 7.72
3rd Support Level 7.38

See More

52-Week High 12.00
Fibonacci 61.8% 8.96
Last Price 8.15
Fibonacci 50% 8.03
Fibonacci 38.2% 7.09
52-Week Low 4.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar